유럽 연합 -
스페인어 -
EMA (European Medicines Agency)
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - clorhidrato de doxorrubicina - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agentes antineoplásicos - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
micofenolato de mofetilo ratiopharm 250 mg capsulas duras efg
ratiopharm españa, s.a. - micofenolato de mofetilo - excipientes: croscarmelosa sodica,laurilsulfato de sodio,laurilsulfato de sodio,propilenglicol,potasio, hidroxido de - inmunosupresores - inmunosupresores selectivos - Ácido micofenólico
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
micofenolato de mofetilo ratiopharm 500 mg comprimidos recubiertos con pelicula efg
ratiopharm españa, s.a. - micofenolato de mofetilo - excipientes: croscarmelosa sodica - inmunosupresores - inmunosupresores selectivos - Ácido micofenólico
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
buprenorfina actavis 2 mg comprimidos sublinguales efg
actavis group ptc ehf - buprenorfina hidrocloruro - excipientes: citrato de sodio (e-331),almidon pregelatinizado,manitol (e-421),lactosa monohidrato - fÁrmacos usados en desÓrdenes adictivos - fármacos usados en la dependencia a opioides - buprenorfina
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
the body shop. vitamin e – gel moisture cream – normal/combination skin- hidratante facial
the body shop chile s.a. - sin formulas
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
crema reductora de líneas y arrugas spf 15 para piel normal/mixta estee lauder time zone line and wrinkle reducing creme spf 15 normal/combination skin
cela cosmÉticos s.a. - sin formulas
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
revlon colorstay makeup combination/oily skin, base maquillaje
laboratorio kadus s.a. - sin formulas
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
tónico equilibrante resfrescante para piel normal/mixta estee lauder perfectly clean fresh balancing lotion normal/combination skin
cela cosmÉticos s.a. - sin formulas
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
bioderma,photoderm nude touch mineral spf50+, claire, sensitive combination/oily skin, protector solar.
socofar s.a. - sin formulas
칠레 -
스페인어 -
ISPC (Instituto de Salud Pública de Chile)
bioderma,photoderm nude touch mineral spf50+, tres claire, sensitive combination/oily skin, protector solar.
socofar s.a. - sin formulas